Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
State
Country
Birmingham : Research Site Updated
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Mobile : Research Site Updated
Glendale : Arizona Center for Cancer Care
A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Peoria : Research Site Updated
Phoenix : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2228820 for Recurrent Ovarian Cancer
Phoenix : Research Site Updated
Phoenix : St. Joseph's Hospital and Medical Center
VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Scottsdale :
A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Scottsdale : Pinnacle Oncology
Tucson : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tucson : Research Site Updated
Bakersfield : Comprehensive Blood and Cancer Center
Berkeley : Research Site Updated
Burbank : Research Site Updated
Concord : Research Site Updated
Corona : Wilshire Oncology Medical Group
Corona : Research Site Updated
La Jolla :
A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Long Beach : Research Site Updated
Long Beach : Long Beach Memorial Medical Center
Los Angeles :
Los Angeles : Research Site Updated
TRINOVA-2: Trebananib in Ovarian Cancer-2
Oceanside : North County Oncology
Oxnard : Research Site Updated
Rancho Mirage : Research Site Updated
Sacramento : Research Site Updated
San Francisco :
San Francisco : Research Site Updated
Santa Maria : Central Coast Medical Oncology
Aurora : Research Site Updated
Englewood : Research Site Updated
Bridgeport : Research Site Updated
Hartford : Research Site Updated
Hartford : St. Francis Hospital and Medical Center
Hartford : Hartford Hospital
New Britain : Research Site Updated
New Britain : The Hospital of Central Connecticut
Norwalk : Research Site Updated
Stamford : Research Site Updated
Miami : Research Site Updated
Orlando : Research Site Updated
Sarasota : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sunrise : Research Site Updated
Tampa : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tampa : Research Site Updated
Savannah : Memorial University Medical Center
GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Augusta : Research Site Updated
Macon : Research Site Updated
Savannah : Memorial Health University Medical Center
Honolulu : Research Site Updated
Decatur : Decatur Memorial Hospital
Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Evanston : Research Site Updated
Hinsdale : Research Site Updated
Hinsdale : Sudarshan K. Sharma, MD, LTD
Joliet :
Maywood : Research Site Updated
Urbana : Research Site Updated
Urbana : Carle Cancer Center
Indianapolis : Indiana University Simon Cancer Center
Indianapolis : Research Site Updated
Indianapolis : St. Vincent Gynecologic Oncology
Lafayette :
Ames : Research Site Updated
Ames : McFarland Clinic
Iowa City :
Westwood : University of Kansas Medical Center
Covington :
Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Baltimore : Research Site Updated
Baltimore : University of Maryland Medical Center
Baltimore : Greater Baltimore Medical Center
Ann Arbor : St. Joseph Mercy Hospital
Detroit : Henry Ford Health System
Grand Rapids : Gynecologic Oncology of West Michigan
Kalamazoo : Research Site Updated
Kalamazoo : West Michigan Cancer Center
Coon Rapids : Minnesota Oncology Coon Rapids Clinic
Edina : Fairview Southdale Hospital
Minneapolis : Abbott Northwestern Hospital
Rochester : Mayo Clinic
Accelerating Gastrointestinal Recovery
St. Louis Park : Research Site Updated
St. Louis Park : Metro Minnesota Clinical Oncology Program
St. Louis Park : Park Nicollet Frauenshuh Cancer Center
St. Paul : Minnesota Oncology St. Paul Cancer Center
Woodbury : Woodbury Clinic - CornerStone Medical Specialty Centre
Jackson : Research Site Updated
Jackson : St. Dominic-Jackson Memorial Hospital
Jackson : University of Mississippi Medical Center
St. Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
St. Louis : Washington University School of Medicine
EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial Ovarian, Fallopian Tube Or Peritoneal Cancer
Billings : Research Site Updated
Omaha : Methodist Estabrook Cancer Center
Las Vegas : Research Site Updated
Las Vegas : Women's Cancer Care Center of Nevada
Reno : Research Site Updated
Lebanon : Research Site Updated
Camden : Cooper Health System / Cooper Cancer Institute
Hackensack : Research Site Updated
New Brunswick : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Voorhees : Research Site Updated
Albuquerque : Research Site Updated
Albuquerque : Southwest Gynecologic Oncology Associates
Albuquerque : University of New Mexico Cancer Center
New York : Biomedical Research Alliance of New York
Ovarian/Fallopian/Primary Peritoneal Cancer
Albany : Research Site Updated
Albany : Women's Cancer Care Associates
Bridgewater :
Brightwaters : Research Site Updated
Brooklyn : SUNY Downstate Medical Center
Buffalo :
Buffalo : Roswell Park Cancer Institute
Lake Success : Research Site Updated
New York :
New York : Columbia University Medical Center
Neoadjuvant Therapy for Ovarian Cancer
New York : Research Site Updated
Asheville : Research Site Updated
Burlington : Research Site Updated
Burlington : Alamance Regional Cancer Center
Chapel Hill : Research Site Updated
Charlotte : Carolinas Medical Center/Blumenthal Cancer Center
Charlotte : Carolinas Medical Center / Levine Cancer Institute
Concord : Carolinas Medical Center - Northeast
Durham :
Durham : Duke Cancer Institute
BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Durham : Research Site Updated
Winston-Salem : Research Site Updated
Akron : Research Site Updated
Akron : Summa Health System
Cleveland : Case Western Reserve University
Cleveland : Cleveland Clinic Cancer Center/Fairview Hospital
Cleveland : Cleveland Clinic Foundation
Cleveland : Research Site Updated
Cleveland : University Hospitals of Cleveland
Columbus : Research Site Updated
Columbus : Ohio State University Medical Center
Kettering : Research Site Updated
Kettering : Women's Cancer Center at Kettering Medical Center
Mayfield Heights : Hillcrest Hospital Cancer Center
Mayfield Heights : Research Site Updated
Mentor : Lake University Ireland Cancer Center
Mentor : Lake University Seidman Cancer Center
Toledo : ProMedica Health System, Inc.
Toledo : Research Site Updated
Oklahoma City : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Oklahoma City :
Oklahoma City : University of Oklahoma Health Sciences Center
Oklahoma City : Research Site Updated
Oklahoma City : Peggy and Charles Stephenson Cancer Center
Tulsa : Research Site Updated
Tulsa : Tulsa Cancer Institute
Bend : Research Site Updated
Abington :
Abington : Abington Memorial Hospital
Abington : Research Site Updated
Abington : Abington Memorial Hospital; Hanjani Institute for Gynecologic Oncology
Bethlehem : Research Site Updated
Philadelphia :
Philadelphia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Philadelphia : Fox Chase Cancer Center
MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
Philadelphia : Research Site Updated
Pittsburgh : Magee-Womens Hospital of UPMC
Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Pittsburgh : Research Site Updated
Pittsburgh : Western Pennsylvania Hospital
West Reading : Research Site Updated
West Reading : Reading Hospital (McGlinn Family Regional Cancer Center)
Providence : Women & Infants' Hospital
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Providence : Women and Infants Hospital
Providence : Research Site Updated
Providence : Women and Infants Hospital of Rhode Island
Charleston : Medical University of South Carolina
Greenville : Research Site Updated
Greenville : Bon Secours St. Francis Hospital
Sioux Falls : CCOP Sioux Community Cancer Consortium
Sioux Falls : Sanford USD Medical Center - Sioux Falls
Sioux Falls : Sanford Clinic Women's Health
Sioux Falls : Sanford Cancer Center-Oncology Clinic
Sioux Falls : Research Site Updated
Chattanooga : Chattanooga GYN Oncology
Chattanooga : Research Site Updated
Memphis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Amarillo : The Don and Sybil Harrington Cancer Center
Austin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Austin : Research Site Updated
Bedford : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Bedford : Research Site Updated
Dallas : Research Site Updated
Fort Sam Houston : Research Site Updated
Fort Worth : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Galveston : Research Site Updated
Houston : UT MD Anderson Cancer Center
First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Houston : The University of Texas MD Anderson Cancer Center
San Antonio : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
San Antonio : Research Site Updated
Tyler : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Ogden : Research Site Updated
Annandale : Research Site Updated
Annandale : Mid Atlantic Pelvic Surgery Associates
Charlottesville : University of Virginia
A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Norfolk : Research Site Updated
Winchester : Research Site Updated
Woodbridge : Research Site Updated
Seattle : Seattle Cancer Care Alliance
Seattle : Northwest Hospital
Seattle : University of Washington Medical Center
Seattle : Pacific Gynecology Specialists
Seattle : Research Site Updated
Wenatchee : Research Site Updated
Green Bay : Research Site Updated
Milwaukee : Research Site Updated
Milwaukee : Medical College of Wisconsin
Oshkosh : Research Site Updated
Sheboygan : Research Site Updated
Wausau : Research Site Updated
West Allis : Research Site Updated
Adelaide : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Auchenflower : Research Site Updated
Carlton : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Footscray : Research Site Updated
Greenslopes : Research Site Updated
Nedlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
New Lambton Heights : Research Site Updated
Parkville : Research Site Updated
Wahroonga : Research Site Updated
Graz : Research Site Updated
Innsbruck : Research Site Updated
Linz : Research Site Updated
Salzburg : Research Site Updated
Wien : Research Site Updated
Gomel : Gomel Regional Clincial Oncology Center
Study of Paclitaxel in Patients With Ovarian Cancer
Minsk : Minsk City Clinical Oncology Hospital
Minsk : Alexandrov National Cancer Center of Belarus
Vitebsk : Vitebsk Regional Clinical Oncology Center
Bonheiden : Research Site Updated
Brasschaat : Research Site Updated
Charleroi : Research Site Updated
Duffel : Research Site Updated
Edegem : Research Site Updated
Gent : Research Site Updated
Hasselt : Research Site Updated
Ieper : Research Site Updated
Kortrijk : Research Site Updated
Leuven : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Leuven : Department of gyneacology, Campus Gasthuisberg
Leuven : Research Site Updated
Liège : Research Site Updated
Libramont : Research Site Updated
Liège : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Namur : Research Site Updated
Oostende : Research Site Updated
Sint-Niklaas : Research Site Updated
Turnhout : Research Site Updated
Wilrijk : Research Site Updated
Yvoir : Research Site Updated
Barretos : Hospital de Câncer de Barretos
Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Belo Horizonte : Oxion Hospital Dia Oncologia
Curitiba : Hospital Erasto Gaertner
Florianópolis : CEPON - Centro de Pesquisas Oncológicas de Santa Catarina
Jaú : Fundação Amaral Carvalho
Porto Alegre : Hospital de Clínicas de Porto Alegre
Rio de Janeiro : INCA - Instituto Nacional de Câncer
Salvador : Núcleo de Oncologia da Bahia
São Paulo : Instituto do Câncer do Estado de São Paulo "Octávio Frias de Oliveira"
São Paulo : Hospital Israelita Albert Einstein
São Paulo : Hospital Santa Marcelina
Shumen : Regional Oncology Dispensary
Sofia : Hospital for a Active Treatment, Tsaritsa Yoanna
Stara Zagora : Regional Oncology Dispensary
Calgary : Research Site Updated
Edmonton : Research Site Updated
Halifax : Research Site Updated
Hamilton :
Kingston : Research Site Updated
London : Research Site Updated
Montreal : Research Site Updated
Quebec : Research Site Updated
Sault Ste. Marie : Research Site Updated
Toronto :
Toronto : Research Site Updated
Rijeka : Klinički Bolnički Centar Rijeka
Split : Klinički Bolnički Centar Split
Olomouc : Onkologická klinika, Fakultní nemocnice Královské Vinohrady
Plzen : Onkologické a radioterapeutické oddělení, Fakultní nemocnice Plzeň
Prague : Radioterapeutická a onkologická klinika, Fakultní nemocnice Královské Vinohrady
Prague : Ústav radiační onkologie, Fakultní nemocnice Na Bulovce
Herlev : Research Site Updated
Herning : Onkologisk Afdelning, Herning Sygehus
København : Research Site Updated
København Ø : Research Site Updated
Kuopio : Kuopion Yliopistollinen Sairaala, Naisten Klinikka
Turku : Turun Yliopistollinen Keskussairaala, Naisten Klinikka,
Aalen : Ostalbklinikum
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Berlin : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Berlin : Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik für Frauenheilkunde
Berlin : Research Site Updated
Düsseldorf : Research Site Updated
Dresden : Research Site Updated
Erlangen : Univerisity Hospital; Dept. of Gynecology & Obstetrics
Erlangen : Research Site Updated
Essen : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Essen : University hospital, Dept. of gynecology & obstetrics
Essen : Research Site Updated
Esslingen : Klinikum Esslingen
Frankfurt : Research Site Updated
Frankfurt am Main : Klinikum der JWG Universität Frankfurt
Frankfurt am Main : Research Site Updated
Freiburg : Universitätsklinikum Freiburg, Frauenklinik
Freiburg : Research Site Updated
Greifswald : Gynecologic Clinic of the Ernst-Moritz-Arndt-University
Hamburg : Research Site Updated
Hannover : Medizinische Hochschule
Hannover : Research Site Updated
Kiel : Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik f. Gynäkologie u. Geburtshilfe
Kiel : Research Site Updated
Konstanz : Research Site Updated
Ludwigsburg : Research Site Updated
München : Research Site Updated
Mainz : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Marburg : Klinikum der Philipps-Universität Marburg, Klinik für Gynäkologie, Gynäkologische Endokrinologie
Marburg : Research Site Updated
Munich : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Offenburg : St. Josefsklinik
Paderborn : St. Vincenz-Krankenhaus
Ravensburg : Research Site Updated
Rostock : Klinikum Südstadt
Rostock : Research Site Updated
Stuttgart : Research Site Updated
Tübingen : Research Site Updated
Ulm : Universitätsklinikum, Universitätsfrauenklinik
Ulm : Research Site Updated
Wiesbaden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Wiesbaden : HSK, Dr. Horst Schmidt Klinik GmbH
Wolfsburg : Klinikum der Stadt Wolfsburg
Athens : Research Site Updated
Thessaloniki : Research Site Updated
Hong Kong : Research Site Updated
Kowloon : Research Site Updated
New Territories : Research Site Updated
Budapest : Research Site Updated
Debercen : Research Site Updated
Kaposvár : Kaposi Mór Megyei Kórház, Onkológiai Tanszék
Miskolc : B.-A.-Z. Megyei Kórház és Egyetemi Oktató Kórház, Észak-Kelet Magyarországi Regionális Klinikai Farmakológiai Központ
Miskolc : Research Site Updated
Nyíregyháza : Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktató Kórháza, Onkoradiológia
Szeged : Research Site Updated
Veszprém : Veszprém Megyei Csolnoky Ferenc Kórház-Rendelőintézet ZRT
Zalaegerszeg : Zala Megyei Kórház, Onkológia
Zalaegerszeg : Research Site Updated
Zalaegerszeg - Pozva : Research Site Updated
Avellino : Research Site Updated
Aviano PN : Research Site Updated
Bari : Research Site Updated
Bologna : Research Site Updated
Brescia : Research Site Updated
Campobasso : Research Site Updated
Genova : Research Site Updated
Milano : Research Site Updated
Napoli : Research Site Updated
Novara : Research Site Updated
Palermo : Research Site Updated
Pisa : Research Site Updated
Roma : Research Site Updated
Torino : Research Site Updated
Fukuoka-shi : Research Site Updated
Kashiwa : Research Site Updated
Kitaadachi-gun : Research Site Updated
Kure-city : Research Site Updated
Kurume-city : Research Site Updated
Morioka-city : Research Site Updated
Nagoya-city : Research Site Updated
Sapporo-city : Research Site Updated
Suntou-gun : Research Site Updated
Tokyo : Research Site Updated
Yonago-city : Research Site Updated
Goyang-si, Gyeonggi-do : Research Site Updated
Seoul : Research Site Updated
Riga : Latvian Oncology Center of Riga Easter Hospital Ltd
Kaunas : Kaunas Medical University Hospital, Oncology Clinic
Vilnius : Institute of Oncology, Vilnius University
Deventer : Research Site Updated
Leiden : Research Site Updated
Nijmegen : Research Site Updated
Rotterdam : Research Site Updated
Grafton, Auckland : Research Site Updated
Tauranga : Research Site Updated
Cluj Napoca : Cluj CF University Hospital
Constanta : Constanta Clinical County Hospital
Craiova : MEDITECH SRL, ORIZONT Polyclinic
Oradea : County Clinical Emergency Hospital Oradea
Arkhangelsk : State Medical Institution, Arkhankelsk Regional Clinical Oncology Center
Barnaul : State Medical Institution, Altai Regional Oncology Center
Chelyabinsk : Chelyabinsk Regional Clinical Oncology Center
Chelyabinsk : Research Site Updated
Ekaterinburg : State Budget-funded Medical Institution of Sverdlovsk Region "Sverdlovsk Regional Oncology Center"
Ivanovo : Research Site Updated
Kazan : Clinical Oncology Center
Kirov : State Treatment and Prevention Institution, Kirov Regional Clinical Oncology Center
Krasnodar : State Medical Institution "Clinical Oncology Center #1" under the Ministry of Health of Krasnodar Region
Krasnodar : Research Site Updated
Magnitogorsk : State Medical Institution, Regional Oncology Center #2, Surgery department
Moscow : State Institution, Moscow City Oncology Hospital #62
Moscow : Federal State Institution, Central Clinical Hospital with Outpatient Unit under the Russian Presidential Administration
Moscow : N.N. Blokhin Cancere Research Center under the Russian Academy of Medical Sciences
Moscow : Research Site Updated
Nizhniy Novgorod : Federal State Institution "Privolzhskiy District Medical Center of Federal Bio-medical Agency"
Obninsk : Research Site Updated
Omsk : State Medical Institution of the Omsk Region, Clincial Oncology center
Orenburg, : State Medical Institution "Orenburg Regional Clinical Oncology Center"
Penza : State Medicinal Institution, Reginal oncology center
Petrozavodsk : State Medical Institution "Republic Oncology Center"
Pyatigorsk : Pyatigorsk Affiliate of State Medical Institution, Stavropol Regional Clinical Oncology Center
Pyatigorsk : Research Site Updated
Saint Petersburg : Research Site Updated
Saint-Petersburg, : State Medical Institution "Leningrad Regional Oncology Center"
Samara : Samara Regional Clinical Oncology Center
Sochi : State Medical Institution, Oncology Center #2 under the Krasnodar Region Healthcare Department
St Petersburg : Federal State Medical Institution, N.N. Petrov Research Institute of Oncology under the Federal Agency for High-Tech Medical Care of the Russian Federation, Oncogynecology Department
St Petersburg : St Petersburg State Medical Institution, City clinical oncology center
Stavropol, : State Medical Institution "Stavropol Regional Clinical Oncology Center"
Tambov : State Medical Institution, Tambov Regional Oncology Center #2
Ufa : Research Site Updated
Voronezh : State Medical Institution, Voronezh Regional Clinical Oncology Center
Voronezh : Research Site Updated
Yaroslavl : State Medical Institution of the Yaroslavl, Region Clinical Oncology Center
Belgrade : Institut za onkologiju i radiologiju Srbije, Klinika za medikalnu onkologiju
Kragujevac : Klinički Bolnički Centar Kragujevac, Centar za onkologiju i radioterapiju
Niš : Klinički Centar Niš, Klinika za onkologiju
Sremska Kamenica : Institut za onkologiju Vojvodine, Klinika za operativnu onkologiju
Singapore : Research Site Updated
Banska Bysterica : Onkologicke oddelenie, FNsP F. D. Roosevelta
Bratilslava : Interne oddelenie, Narodny onkologicky ustav
Bratislava : Research Site Updated
Kosice : Research Site Updated
Presov : Research Site Updated
Simferopol : Crimean Republicann Oncology Dispensary
Badalona : Research Site Updated
Barcelona : Research Site Updated
El Palmar : Research Site Updated
Lleida : Research Site Updated
Madrid : Research Site Updated
Oviedo : Research Site Updated
Palma de Mallorca : Research Site Updated
Valencia : Research Site Updated
Zaragoza : Research Site Updated
Göteborg : Divisionen för Onkologi , Sahlgrenska Universitetssjukhuset
Linköping : Onkologikliniken, Universitetssjukhuset Linköping
Lund : Onkologiska Kliniken, Universitetssjukhuset Lund
Örebro : Kliniken för Gynekologisk Onkologi, Regionsjukhuset
Umeå : Gyn-Onkologiska kliniken, Norrlands universitetssjukhus
Tainan : Research Site Updated
Taipei : Research Site Updated
Cherkassy : Cherkassy Regional Oncological Centre
Chernivtsy : Cherkassy Regional Oncological Centre
Dnepropetrovsk : KZ, City Clinical Hospital #19 City oncology Center
Dnipropetrovsk : Multi-profile clinical hospital#4
Donetsk : Donetsk Regional Antitumor Center
Ivano-Frankivsk, 76018 : Ivano-Frankivsk Regional Oncology Center
Kharkiv : "S.P. Grygoryev Institute of Medical Radiology of the Academy of Medical Science of Ukraine
Kharkiv : Kharkiv Regional Clinical Oncology
Kherson : Kherson Reginal Oncological Center
Kiev : Kiev City Oncology center
Kiev : DU, National Institute of Cancer, Department of Oncogynecology
Kyiv : Kyiv Regional Oncology Center
Lugansk : Lugansk Regional Oncology Center
Odessa : Odessa City Oncological Center
Sumy : Sumy Regional Onclolgy Center
Ternopil : Ternopil Regional Oncology Hospital
Edinburgh :
Liverpool :
Manchester : Research Site Updated
Northwood : Research Site Updated
Nottingham : Research Site Updated
Poole : Research Site Updated
